Novartis AG (NVS)
97.74
+0.46
(+0.48%)
USD |
NYSE |
May 06, 16:00
97.74
0.00 (0.00%)
After-Hours: 20:00
Novartis Market Cap: 199.42B for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 198.47B |
| May 02, 2024 | 198.61B |
| May 01, 2024 | 198.94B |
| April 30, 2024 | 198.18B |
| April 29, 2024 | 198.10B |
| April 26, 2024 | 198.82B |
| April 25, 2024 | 202.12B |
| April 24, 2024 | 200.67B |
| April 23, 2024 | 198.49B |
| April 22, 2024 | 194.08B |
| April 19, 2024 | 192.53B |
| April 18, 2024 | 188.88B |
| April 17, 2024 | 189.92B |
| April 16, 2024 | 190.17B |
| April 15, 2024 | 192.63B |
| April 12, 2024 | 190.82B |
| April 11, 2024 | 192.49B |
| April 10, 2024 | 192.57B |
| April 09, 2024 | 195.49B |
| April 08, 2024 | 194.82B |
| April 05, 2024 | 195.45B |
| April 04, 2024 | 197.69B |
| April 03, 2024 | 192.55B |
| April 02, 2024 | 192.63B |
| April 01, 2024 | 195.61B |
| Date | Value |
|---|---|
| March 28, 2024 | 197.72B |
| March 27, 2024 | 195.98B |
| March 26, 2024 | 194.74B |
| March 25, 2024 | 195.68B |
| March 22, 2024 | 196.70B |
| March 21, 2024 | 196.39B |
| March 20, 2024 | 196.33B |
| March 19, 2024 | 196.88B |
| March 18, 2024 | 196.06B |
| March 15, 2024 | 198.82B |
| March 14, 2024 | 200.58B |
| March 13, 2024 | 202.36B |
| March 12, 2024 | 203.93B |
| March 11, 2024 | 207.20B |
| March 08, 2024 | 205.85B |
| March 07, 2024 | 204.26B |
| March 06, 2024 | 209.80B |
| March 05, 2024 | 208.70B |
| March 04, 2024 | 208.43B |
| March 01, 2024 | 208.61B |
| February 29, 2024 | 206.39B |
| February 28, 2024 | 208.94B |
| February 27, 2024 | 210.84B |
| February 26, 2024 | 211.05B |
| February 23, 2024 | 212.38B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
160.07B
Minimum
Mar 23 2020
224.26B
Maximum
Feb 12 2020
197.72B
Average
197.83B
Median
Apr 27 2022
Market Cap Benchmarks
| Roche Holding AG | 191.91B |
| Sandoz Group AG | 14.76B |
| Amgen Inc | 160.61B |
| Incyte Corp | 12.15B |
| MorphoSys AG | 2.713B |
Market Cap Related Metrics
| PE Ratio | 13.33 |
| PS Ratio | 4.062 |
| PEG Ratio | 0.1062 |
| Price to Book Value | 5.026 |
| Price to Free Cash Flow | 19.79 |
| Price | 97.74 |
| Earnings Yield | 7.50% |
| PEGY Ratio | 0.1030 |
| Operating PE Ratio | 19.07 |
| Normalized PE Ratio | 22.11 |